In part two of a series, columnist Jennifer Lynne talks with Chip Hailey about his experience receiving gene therapy for hemophilia B.

Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor's breakthrough RNA-based diagnostic approach at the RNA Society's 30th Annual Meeting. The talk, presented by Dr.

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator ...

For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body -- a job commonly given to adeno-associated viruses (AAV). To improve the AAV ...

A pivotal medical milestone has been reached. For the first time ever, researchers have used a personalized CRISPR-based gene ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Rocket Pharmaceuticals shares plummeted 60% Tuesday after the firm said it halted a study of a gene-therapy drug for Danon ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

For the first time, doctors have treated an infant with a rare genetic disease with a gene-editing therapy tailored ...

US researchers have engineered a novel gene therapy to target the airway and lungs via a nasal spray. For gene therapy to ...